NIKITIDIS; Antonios

Patent Applications and Registrations

Patent applications and USPTO patent grants for NIKITIDIS; Antonios.The latest application filed is for "dual inhibitors of phosphatidylinositol 3-kinase delta & gamma".

Company Profile

2.10.13

NIKITIDIS; Antonios - Sodertalje SE
Nikitidis; Antonios - Molndal SE
Nikitidis; Antonios - Lund N/A SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dual Inhibitors Of Phosphatidylinositol 3-kinase Delta & Gamma App 20210246130 - PERRY; Matthew ; et al.	2021-08-12
(S)-2-(1-cyclopropylethyl)-5-(4-methyl-2-((6-(2-oxopyrrolidin-1-yl)pyridin- -2-yl)amino) thiazol-5-yl)-7-(methylsulfonyl)isoindolin-1-one as a phosphatidylinositol 3-kinase inhibitor Grant 10,961,236 - Perry , et al. March 30, 2	2021-03-30
5-[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1 H-isoindol-1 -one Derivatives And Their Use As Dual Inhibitors Of Phosphatidylinositol 3-kinase Delta & Gamma App 20200308164 - PERRY; Matthew ; et al.	2020-10-01
Compounds And Uses App 20170216283 - Ronn; Robert ; et al.	2017-08-03
Compounds and uses Grant 9,657,001 - Ronn , et al. May 23, 2	2017-05-23
Compounds And Uses App 20160326143 - Ronn; Robert ; et al.	2016-11-10
2-pyridone derivatives as neutrophil elastase inhibitors and their use Grant 8,501,784 - Andersson , et al. August 6, 2	2013-08-06
Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase Grant 8,466,284 - Chapman , et al. June 18, 2	2013-06-18
2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial Grant 8,410,114 - Hansen , et al. April 2, 2	2013-04-02
2-pyrazinone Derivatives For The Treatment Of Disease Or Condition In Which Inhibition Of Neutrophil Elastase Activity Is Beneficial App 20120108610 - Hansen; Peter ; et al.	2012-05-03
2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial Grant 8,114,881 - Hansen , et al. February 14, 2	2012-02-14
2-pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use App 20120035157 - Andersson; Marjana ; et al.	2012-02-09
2-pyridone derivatives as neutrophil elastase inhibitors and their use Grant 8,063,073 - Hansen , et al. November 22, 2	2011-11-22
Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase App 20100280048 - Ainge; Debra ; et al.	2010-11-04
2-pyrazinone Derivatives For The Treatment Of Disease Or Condition In Which Inhibition Of Neutrophil Elastase Activity Is Beneficial App 20090209555 - Hansen; Peter ; et al.	2009-08-20
2-pyridine Derivatives As Inhibitors Of Neutrophile Elastase App 20090131483 - Hansen; Peter ; et al.	2009-05-21
2-pyridine Derivatives As Inhibitors Of Neutrophile Elastase App 20090105239 - Brimert; Thomas ; et al.	2009-04-23
Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators App 20080153799 - Laurent; David ; et al.	2008-06-26
2-Pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use App 20070203129 - Andersson; Marjana ; et al.	2007-08-30
2-Pyridone derivatives as neutrophil elastase inhibitors and their use App 20070043036 - Hansen; Peter ; et al.	2007-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.